₹1,252.2
▼ -16.24 -1.28%
17 Jul 2026
NSE Listed
3B BlackBio DX Ltd. (3BBLACKBIO)
Volume: 21,455Avg Vol 1W: 24,531.8Avg Vol 1M: 11,80352W Range:₹1,085₹1,441.5
Key Ratios
Checked 4h agoMarket Cap₹1,089 Cr
Current Price₹1,252.2
Previous Close₹1,268.44
High / Low (52w)₹1,441.5 / ₹1,085
Volume21,455
Avg Vol (1W)24,531.8
Avg Vol (1M)11,803
Stock P/E18.58
Book Value₹377.96
Dividend Yield40%
ROE18.06%
ROA15.85%
Revenue (TTM)₹112 Cr
Revenue Growth—
Profit Margin41.29%
Total Debt—
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹68.26
P/B3.33
Debt / Equity0
50 DMA₹1,202.78
200 DMA₹1,225.36
Day change-1.28%
Price Chart
₹1,252.2▼ 3.82% · 1Y
2026-04-202026-07-16
20-day avg volume: 12K shares
Pros
- Healthy return on equity of 18.1%.
- Pays a dividend yield of 40.0%.
- Company is almost debt-free.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹19 Cr | ₹29 Cr | ₹25 Cr | ₹23 Cr | ₹22 Cr | ₹34 Cr | ₹50 Cr | ₹35 Cr |
| EBITDA | ₹14 Cr | ₹19 Cr | ₹18 Cr | ₹13 Cr | ₹16 Cr | ₹20 Cr | ₹27 Cr | ₹15 Cr |
| Net Profit | ₹11 Cr | ₹15 Cr | ₹13 Cr | ₹8 Cr | ₹13 Cr | ₹15 Cr | ₹22 Cr | ₹10 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹23 Cr | ₹24 Cr | ₹30 Cr | ₹230 Cr | ₹88 Cr | ₹69 Cr | ₹87 Cr | ₹112 Cr |
| EBITDA | ₹5 Cr | ₹7 Cr | ₹10 Cr | ₹152 Cr | ₹43 Cr | ₹36 Cr | ₹44 Cr | ₹64 Cr |
| Net Profit | ₹3 Cr | ₹5 Cr | ₹8 Cr | ₹114 Cr | ₹32 Cr | ₹26 Cr | ₹32 Cr | ₹48 Cr |
| EPS | 5.37 | 8.2 | 10.25 | 152.01 | 43.4 | 30.27 | 37.46 | 55.66 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹30 Cr | ₹36 Cr | ₹45 Cr | ₹194 Cr | ₹192 Cr | ₹214 Cr | ₹248 Cr | ₹296 Cr |
| Total Liabilities | ₹12 Cr | ₹14 Cr | ₹11 Cr | ₹45 Cr | ₹20 Cr | ₹18 Cr | ₹23 Cr | ₹25 Cr |
| Equity | ₹19 Cr | ₹23 Cr | ₹34 Cr | ₹148 Cr | ₹172 Cr | ₹196 Cr | ₹225 Cr | ₹271 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹3 Cr | ₹5 Cr | ₹9 Cr | ₹135 Cr | ₹48 Cr | ₹29 Cr | ₹38 Cr | ₹58 Cr |
| Investing | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹-70 Cr | ₹-28 Cr | ₹15 Cr | ₹-20 Cr | ₹-34 Cr |
| Financing | ₹0 Cr | ₹-1 Cr | ₹1 Cr | ₹-2 Cr | ₹-15 Cr | ₹-5 Cr | ₹-4 Cr | ₹-3 Cr |
| Free Cash Flow | ₹3 Cr | ₹5 Cr | ₹9 Cr | ₹135 Cr | ₹48 Cr | ₹29 Cr | ₹38 Cr | ₹58 Cr |
Shareholding
Promoter 40.95% Institutions 4.65% Public 54.4%
Efficiency & Working Capital
ROCE23.6%
Interest Coverage582.8
Dividend Payout—
Debtor Days138 d
Inventory Days33 d
Payable Days7 d
Cash Conversion Cycle164 d
Working Capital Days171 d
Shareholding Details
As of 2026-06-30
Promoter41%
FII2.5%
DII2.1%
Institutions4.7%
Public54.4%
Promoter Pledge0%
No. of Shareholders11,049
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Feb 2024 | Feb 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 40.9% | 41% |
| FIIs | 3% | 3% | 3% | 3.3% | 3.3% | 2.7% | 2.5% | 2.7% | 2.6% | 2.6% | 2.6% | 2.5% |
| DIIs | 1.9% | 1.9% | 1.9% | 2% | 2% | 1.7% | 1.6% | 1.8% | 1.8% | 1.9% | 2% | 2.1% |
| Public | 53.9% | 53.9% | 53.9% | 53.5% | 53.5% | 54.3% | 54.6% | 54.3% | 54.3% | 54.3% | 54.5% | 54.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 9,753 | 9,753 | 9,753 | 9,399 | 9,586 | 10,166 | 10,345 | 10,619 | 10,709 | 10,507 | 10,616 | 11,049 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Mithla Dubey | Shareholding of Promoter and Promoter Group | 12.4% | 10,59,770 |
| Mithala Laboratories Private Limited | Shareholding of Promoter and Promoter Group | 9.6% | 8,20,700 |
| Dhirendra Dubey | Shareholding of Promoter and Promoter Group | 8.5% | 7,25,098 |
| Rashi Daga | Public Shareholding | 5.6% | 4,82,759 |
| Prateek Goel | Public Shareholding | 5.1% | 4,41,435 |
| Own Infracon Private Limited | Public Shareholding | 4.4% | 3,78,077 |
| Nikhil Kuber Dubey | Shareholding of Promoter and Promoter Group | 4.2% | 3,58,080 |
| Maj Navraj Singh Grewal | Public Shareholding | 2.7% | 2,27,500 |
| 2b Blackbio S.l. Spain | Shareholding of Promoter and Promoter Group | 2.5% | 2,12,570 |
| Ram Kuber Dhirendra Kumar | Shareholding of Promoter and Promoter Group | 2.3% | 1,94,700 |
| Ark Global Emerging Companies Lp | Public Shareholding | 1.9% | 1,66,899 |
| Dalmus Performance Focused Fund | Public Shareholding | 1.9% | 1,60,173 |
| Shalu Aggarwal | Public Shareholding | 1.1% | 91,061 |
| Sandeep Kapadia | Public Shareholding | 1% | 86,000 |
| Rajesh Kumar Dubey | Shareholding of Promoter and Promoter Group | 0.4% | 37,700 |
| Madhulika Dubey | Shareholding of Promoter and Promoter Group | 0.3% | 29,000 |
| Santosh Kumar Dubey | Shareholding of Promoter and Promoter Group | 0.3% | 26,200 |
| Mahesh Kumar Upadhyay | Shareholding of Promoter and Promoter Group | 0.3% | 23,850 |
| Anamika Dubey | Shareholding of Promoter and Promoter Group | 0.3% | 22,000 |
| Sanjay Kumar Dubey | Shareholding of Promoter and Promoter Group | 0.1% | 5,100 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Santosh Kumar Dubey | 0 | 0% | 2026-06-30 |
| Rajesh Kumar Dubey | 0 | 0% | 2026-06-30 |
| Sanjay Kumar Dubey | 0 | 0% | 2026-06-30 |
| Mahesh Kumar Upadhyay | 0 | 0% | 2026-06-30 |
| Mithala Laboratories Private Limited | 0 | 0% | 2026-06-30 |
| Mithla Dubey | 0 | 0% | 2026-06-30 |
| Nikhil Kuber Dubey | 0 | 0% | 2026-06-30 |
| Dhirendra Dubey | 0 | 0% | 2026-06-30 |
| Ram Kuber Dhirendra Kumar | 0 | 0% | 2026-06-30 |
| Madhulika Dubey | 0 | 0% | 2026-06-30 |
| Anamika Dubey | 0 | 0% | 2026-06-30 |
| 2b Blackbio S.l. Spain | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| D K Dubey | Chairman / Executive Director / M D / Promoter | 2025 |
| N K Dubey | ED / WTD / CFO / Promoter | 2025 |
| Mithala Dubey | Non Executive Director | 2025 |
| Abdul Moin Khan | Independent Non Exe. Director | 2025 |
| Harihar Prasad Thapak | Independent Non Exe. Director | 2025 |
| Vivek Saihgal | Independent Non Exe. Director | 2025 |
| Navneet Kaur | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Agro-Chemical based Products | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 16 | 9 | 9 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-19 | ₹4 (40%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 3 | 0 | 3 |
| 2025 | 0 | 0 | 0 | 3 | 0 | 3 |
| 2025 | 0 | 0 | 0 | 3 | 0 | 3 |
Insider / Designated-Person Trades
14 recent disclosure(s)
DHIRENDRA DUBEYAcquisition · 1,000
MAHESH KUMAR UPADHYAYDisposal · 150
MAHESH KUMAR UPADHYAYDisposal · 250
MAHESH KUMAR UPADHYAY RevisedDisposal · 250
MAHESH KUMAR UPADHYAYDisposal · 250
ABDUL MOIN KHANDisposal · 500
Substantial Acquisitions (SAST)
12 disclosure(s)
Market24/06/2026 · 1,000
Market23/12/2025 - 24/12/2025 · 400
Market21/03/2025 · 250
Allotment10/10/2023 · 4,16,500
Allotment10/10/2023 · 4,16,500
Allotment10/10/2023 · 6,58,070
Company Information
🌐 www.kilpest.com ↗
📍 7-C Industrial Area, Govindpura, Bhopal, Madhya Pradesh, 462023
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search